Recent Advances in Phage-Based Therapeutics for Multi-Drug Resistant Acinetobacter baumannii

Yujing Tan1, Jianhui Su1, Minghui Fu1

  • 1School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, China.

Insights

Bacteriophage therapy shows promise for treating Acinetobacter baumannii infections, especially with novel combinations and delivery systems. This review highlights recent advances and future directions in combating this opportunistic pathogen.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Biotechnology

Background:

  • Acinetobacter baumannii is a significant opportunistic pathogen frequently causing hospital-acquired infections.
  • The rise of antibiotic resistance has renewed interest in phage therapy as a viable alternative treatment.
  • Phage therapy involves using bacteriophages (viruses that infect bacteria) to target and eliminate specific bacterial pathogens.

Purpose of the Study:

  • To review recent advancements in phage therapy for Acinetobacter baumannii infections over the last five years.
  • To highlight innovative strategies such as combining phages with other therapeutic agents and advanced delivery systems.
  • To discuss current challenges and future prospects for phage-based treatments against Acinetobacter baumannii.

Main Methods:

  • Literature review of scientific publications from the past five years focusing on Acinetobacter baumannii and phage therapy.
  • Analysis of studies exploring combined therapeutic approaches, including phage-photosensitizer combinations.
  • Examination of research on phage encapsulation techniques using microparticles and hydrogels for improved delivery.

Main Results:

  • Significant progress has been made in developing phage-based treatments for Acinetobacter baumannii.
  • Combinatorial strategies, such as phage-photosensitizer therapy, show enhanced efficacy.
  • Encapsulation of phages in microparticles and hydrogels improves their stability and targeted delivery.
  • Material science innovations are crucial for advancing phage therapy effectiveness.

Conclusions:

  • Phage therapy represents a promising strategy for combating Acinetobacter baumannii infections, particularly in the post-antibiotic era.
  • Innovative approaches, including synergistic combinations and advanced drug delivery systems, are key to overcoming therapeutic challenges.
  • Further research into material science and phage engineering will be critical for the future clinical application of phage therapy against Acinetobacter baumannii.

Related Concept Videos

Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
71.4K
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
64
DNA Bacteriophages01:26

DNA Bacteriophages

Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
85
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
116
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
68